246 related articles for article (PubMed ID: 19276381)
1. Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells.
Leroy C; Fialin C; Sirvent A; Simon V; Urbach S; Poncet J; Robert B; Jouin P; Roche S
Cancer Res; 2009 Mar; 69(6):2279-86. PubMed ID: 19276381
[TBL] [Abstract][Full Text] [Related]
2. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
[TBL] [Abstract][Full Text] [Related]
3. Identification and phenotypic characterization of a subpopulation of T84 human colon cancer cells, after selection on activated endothelial cells.
Alessandro R; Flugy AM; Russo D; Stassi G; De Leo A; Corrado C; Alaimo G; De Leo G
J Cell Physiol; 2005 Apr; 203(1):261-72. PubMed ID: 15484219
[TBL] [Abstract][Full Text] [Related]
4. Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization.
Sirvent A; Bénistant C; Pannequin J; Veracini L; Simon V; Bourgaux JF; Hollande F; Cruzalegui F; Roche S
Oncogene; 2010 Mar; 29(9):1303-15. PubMed ID: 20010872
[TBL] [Abstract][Full Text] [Related]
5. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
[TBL] [Abstract][Full Text] [Related]
6. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.
Hui AY; Meens JA; Schick C; Organ SL; Qiao H; Tremblay EA; Schaeffer E; Uniyal S; Chan BM; Elliott BE
J Cell Biochem; 2009 Aug; 107(6):1168-81. PubMed ID: 19533669
[TBL] [Abstract][Full Text] [Related]
7. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
[TBL] [Abstract][Full Text] [Related]
8. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS
Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.
Joshi B; Strugnell SS; Goetz JG; Kojic LD; Cox ME; Griffith OL; Chan SK; Jones SJ; Leung SP; Masoudi H; Leung S; Wiseman SM; Nabi IR
Cancer Res; 2008 Oct; 68(20):8210-20. PubMed ID: 18922892
[TBL] [Abstract][Full Text] [Related]
10. Analysis of SRC oncogenic signaling in colorectal cancer by stable isotope labeling with heavy amino acids in mouse xenografts.
Sirvent A; Vigy O; Orsetti B; Urbach S; Roche S
Mol Cell Proteomics; 2012 Dec; 11(12):1937-50. PubMed ID: 23023324
[TBL] [Abstract][Full Text] [Related]
11. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation.
Zhu S; Bjorge JD; Fujita DJ
Cancer Res; 2007 Nov; 67(21):10129-37. PubMed ID: 17974954
[TBL] [Abstract][Full Text] [Related]
12. Src transduces signaling via growth hormone (GH)-activated GH receptor (GHR) tyrosine-phosphorylating GHR and STAT5 in human leukemia cells.
Manabe N; Kubota Y; Kitanaka A; Ohnishi H; Taminato T; Tanaka T
Leuk Res; 2006 Nov; 30(11):1391-8. PubMed ID: 16650892
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction by focal adhesion kinase in cancer.
Zhao J; Guan JL
Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.
Chiu ST; Chang KJ; Ting CH; Shen HC; Li H; Hsieh FJ
Carcinogenesis; 2009 Sep; 30(9):1475-86. PubMed ID: 19483190
[TBL] [Abstract][Full Text] [Related]
15. Decreased CHK protein levels are associated with Src activation in colon cancer cells.
Zhu S; Bjorge JD; Cheng HC; Fujita DJ
Oncogene; 2008 Mar; 27(14):2027-34. PubMed ID: 17934522
[TBL] [Abstract][Full Text] [Related]
16. Src-Tyrosine kinases are major agents in mitochondrial tyrosine phosphorylation.
Tibaldi E; Brunati AM; Massimino ML; Stringaro A; Colone M; Agostinelli E; Arancia G; Toninello A
J Cell Biochem; 2008 Jun; 104(3):840-9. PubMed ID: 18247338
[TBL] [Abstract][Full Text] [Related]
17. Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells.
Di Florio A; Capurso G; Milione M; Panzuto F; Geremia R; Delle Fave G; Sette C
Endocr Relat Cancer; 2007 Mar; 14(1):111-24. PubMed ID: 17395980
[TBL] [Abstract][Full Text] [Related]
18. [Tyrosine kinases of the Src family, enzymes with multiple functions: from the growth of fibroblasts to the migration of epithelial cells].
Roche S
C R Seances Soc Biol Fil; 1998; 192(2):357-65. PubMed ID: 9759377
[TBL] [Abstract][Full Text] [Related]
19. Increased tyrosine phosphorylation of PSD-95 by Src family kinases after brain ischaemia.
Du CP; Gao J; Tai JM; Liu Y; Qi J; Wang W; Hou XY
Biochem J; 2009 Jan; 417(1):277-85. PubMed ID: 18721130
[TBL] [Abstract][Full Text] [Related]
20. Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC).
Amanchy R; Kalume DE; Iwahori A; Zhong J; Pandey A
J Proteome Res; 2005; 4(5):1661-71. PubMed ID: 16212419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
